Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Forecasting surprise costs reduces anxiety and keeps goals in sight. Explore practical techniques to anticipate and prepare efficiently.
28,655 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Bitcoin breaks through the $67,000 level as sentiment improves and risk-on behavior returns to crypto markets. HYPE a...
As a new Federal Reserve chair makes his debut, Jim Cramer argues markets should expect stability, not shocks. Trader...
Bitcoin rebounds after a Strategy-driven Bitcoin sale rattled markets, while XRP drifts further away from crucial sup...
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
In his first shareholder letter, Berkshire Hathaway’s new leader pledges continuity, a robust balance sheet, and read...
A fresh payroll revision erased 161,000 jobs from the headline numbers, intensifying volatility as Bitcoin navigates ...
Fresh data on unemployment filings show the labor market staying resilient. The big question remains whether the econ...
Palantir surged into focus after blowout Q1 results and a fresh Buy rating from Argus with a $190 target, raising que...
Bitcoin slides below key price floors as traders brace for a new Fed Chair and policy shifts. The week saw mixed acti...
Bitcoin remains the anchor as June approaches, with institutional buyers scooping up BTC during pullbacks. This piece...
In 2026, social security’s special minimum is fading for new retirees. Fewer than 30,000 people still qualify, with m...